Business Description
GeneTether Therapeutics Inc
NAICS : 325412
SIC : 3741
ISIN : CA37187D1087
Description
GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin. Their platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.97 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -122.4 | |||||
| 3-Year EPS without NRI Growth Rate | -91.3 | |||||
| 3-Year FCF Growth Rate | -86.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -94.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 36.4 | |||||
| Quick Ratio | 36.4 | |||||
| Cash Ratio | 35.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 5.6 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -44.11 | |||||
| ROA % | -42.51 | |||||
| ROIC % | -1285.62 | |||||
| ROC (Joel Greenblatt) % | -602.4 | |||||
| ROCE % | -47.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.94 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | 0.13 | |||||
| EV-to-EBITDA | 0.13 | |||||
| EV-to-FCF | 0.21 | |||||
| Price-to-Net-Current-Asset-Value | 1 | |||||
| Price-to-Net-Cash | 1 | |||||
| Earnings Yield (Greenblatt) % | 769.23 | |||||
| FCF Yield % | -35.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GNTTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GeneTether Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.008 | ||
| Beta | 0 | ||
| Volatility % | 101.76 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.01 | ||
| 12-1 Month Momentum % | -94.74 | ||
| 52-Week Range ($) | 0.01 - 0.19 | ||
| Shares Outstanding (Mil) | 38.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GeneTether Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GeneTether Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
GeneTether Therapeutics Inc Frequently Asked Questions
What is GeneTether Therapeutics Inc(GNTTF)'s stock price today?
The current price of GNTTF is $0.01. The 52 week high of GNTTF is $0.19 and 52 week low is $0.01.
When is next earnings date of GeneTether Therapeutics Inc(GNTTF)?
The next earnings date of GeneTether Therapeutics Inc(GNTTF) is .
Does GeneTether Therapeutics Inc(GNTTF) pay dividends? If so, how much?
GeneTether Therapeutics Inc(GNTTF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers